Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa
- PMID: 28056015
- PMCID: PMC5215784
- DOI: 10.1371/journal.pntd.0005163
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Uniting to Combat Neglected Tropical Diseases. The London Declaration. [cited 2016 May 10]. http://unitingtocombatntds.org/resource/london-declaration.
-
- Global programme to eliminate lymphatic filariasis: progress report, 2015. Wkly Epidemiol Rec. 2016;91(39):441–55. - PubMed
-
- Evans DS, Unnasch TR, Richards FO. Onchocerciasis and lymphatic filariasis elimination in Africa: it's about time. Lancet. 2015;385(9983):2151–2. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
